Natural Product: NPC483291| Natural Product ID | NPC483291 |
|
Common Name
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
| JWZZKOKVBUJMES-UHFFFAOYSA-N |
| IUPAC Name | n.a. |
| Synonyms | |
| Synthetic Gene Cluster | n.a. |
| ChEMBL Identifier | n.a. |
| PubChem CID |
3779 |
| Chemical Classification |
|
The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.
Chemical Representations
| Standard InCHIKey | JWZZKOKVBUJMES-UHFFFAOYSA-N |
| Standard InCHI | InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3 |
| SMILES | CC(C)NCC(c1ccc(c(c1)O)O)O |
  Calculated Properties| Molecular Weight:   | 211.12 | Volume:   | 219.714 Van der Waals volume.
|
| Dense:   | 0.961 | LogP:   | -0.463 The logarithm of the n-octanol/water distribution coefficients.
|
| logD7.4:   | 0.051 The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
|
LogS:   | -0.678 The logarithm of aqueous solubility value.
|
| Rotatable Bonds:   | 4.0 | Rigid Bonds:   | 6.0 |
| TPSA:   | 72.72 Topological Polar Surface Area.
|
H-Bond Acceptor:   | 4.0 |
| H-Bond Donor:   | 4.0 | Rings:   | 1.0 |
| Heavy Atoms:   | 4.0 |
| QED Drug-Likeness Score:   | 0.563 | GASA:   | 0.0 GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
|
| Synthetic Accessibility Score:   | 2.599 | Fsp3:   | 0.455 |
| MCE-18:   | 16.0 MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
|
Lipinski Rule-of-5:   | Rejected |
| Pfizer Rule:   | Rejected | GSK Rule:   | Rejected |
| Golden Triangle Rule:   | Rejected | BMS Rule:   | 0 |
| Chelating Alert:   | 1 | PAINS Alert:   | 1 |
| Colloidal aggregators:   | 0.072 | Fluc inhibitor:   | 0.0 The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
|
| Blue fluorescence:   | 0.008 The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
|
Green fluorescence:   | 0.079 The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
|
| Reactive compounds:   | 0.014 | Promiscuous compounds:   | 0.983 |
| Caco-2 Permeability:   | -5.459 | MDCK Permeability:   | -5.001 |
| Pgp-inhibitor:   | 0.0 | Pgp-substrate:   | 0.109 |
| PAMPA:   |
0.955 The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
|
Human Intestinal Absorption (HIA):   | 0.002 |
| 20% Bioavailability (F20%):   | 0.96 | 30% Bioavailability (F30%):   | 0.891 |
| 50% Bioavailability (F50%):   | 1.0 |
| Blood-Brain-Barrier Penetration (BBB):   | 0.0 | MRP1:   | 0.935 |
| Plasma Protein Binding (PPB):   | 35.682% | Volume Distribution (VD):   | 0.129 |
| Fu: |
63.772% The fraction unbound in plasms.
|
OATP1B1 inhibitor:   | 0.737 |
| OATP1B3 inhibitor:   | 0.84 | BCRP inhibitor:   | 0.003 |
| BSEP inhibitor:   | 0.0 |
| CYP1A2-inhibitor:   | 0.0 | CYP1A2-substrate:   | 0.0 |
| CYP2C19-inhibitor:   | 0.075 | CYP2C19-substrate:   | 0.0 |
| CYP2C9-inhibitor:   | 0.0 | CYP2C9-substrate:   | 0.0 |
| CYP2D6-inhibitor:   | 0.992 | CYP2D6-substrate:   | 0.063 |
| CYP3A4-inhibitor:   | 0.001 | CYP3A4-substrate:   | 0.0 |
| CYP2B6-substrate:   | 0.0 | CYP2C8-inhibitor:   | 0.04 |
| HLM stability:   |
0.991 Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.
|
| Clearance (CL):   | 17.977 | Half-life (T1/2):   | 2.067 |
| hERG Blockers:   | 0.209 | hERG Blockers (10um):   | 0.631 |
| Human Hepatotoxicity (H-HT):   | 0.343 | Drug-induced Liver Injury (DILI):   | 0.002 |
| AMES Toxicity:   | 0.072 | Rat Oral Acute Toxicity:   | 0.423 |
| Maximum Recommended Daily Dose:   | 0.942 | Skin Sensitization:   | 0.588 |
| Carcinogencity:   | 0.084 | Eye Corrosion:   | 0.042 |
| Eye Irritation:   | 0.351 | Respiratory Toxicity:   | 0.918 |
| Drug-induced Neurotoxicity:   | 0.068 | Ototoxicity:   | 0.877 |
| Hematotoxicity:   | 0.083 | Drug-induced Nephrotoxicity:   | 0.036 |
| Genotoxicity:   | 0.98 | RPMI-8226 Immunitoxicity:   | 0.01 |
| A549 Cytotoxicity:   | 0.016 | Hek293 Cytotoxicity:   | 0.014 |
| BCF:   |
0.513 Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
|
IGC50:   |
2.748 48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
|
| LC50DM:   |
4.21 48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
|
LC50FM:   |
3.615 96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].
|
  Species Source| Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
|---|---|---|---|---|---|---|---|---|
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | n.a. | n.a. | n.a. | DOI[10.1016/j.carres.2012.01.012] |
| NPO6158 | Jasminum multiflorum | Species | Oleaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[2607347] |
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[26562741] |
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[29517238] |
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[31625751] |
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | n.a. | Along the Valencian coast, Spain | 2020-Jun&Jul |
PMID[35161358] |
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | n.a. | n.a. | n.a. | Database[COCONUT] |
| NPO6158 | Jasminum multiflorum | Species | Oleaceae | Eukaryota | n.a. | n.a. | n.a. | Database[COCONUT] |
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | Herb | n.a. | n.a. | Database[FooDB] |
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | Plant | n.a. | n.a. | Database[FooDB] |
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | Seed | n.a. | n.a. | Database[FooDB] |
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
| NPO4640 | Portulaca oleracea | Species | Portulacaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
| NPO6158 | Jasminum multiflorum | Species | Oleaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  NP Quantity Composition/Concentration| Organism ID | Organism Name | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
|---|
Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Biological Activity
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 1000.0 | nM | DOI[10.1016/S0960-894X(96)00603-8] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 87.1 | nM | PMID[12502364] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 87.0 | nM | PMID[12502364] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 3.162 | nM | PMID[11806709] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 0.1585 | nM | PMID[11806709] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 1.0 | nM | PMID[11806709] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | Ki | = | 1584.89 | nM | PMID[10377236] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | Ki | = | 676.08 | nM | PMID[10377236] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | Ki | = | 18620.87 | nM | PMID[10377236] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 0.97 | nM | PMID[15603933] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 0.084 | nM | PMID[15603933] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 2.0 | nM | PMID[15603933] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 3.162 | nM | PMID[16640337] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 0.1585 | nM | PMID[16640337] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 1.0 | nM | PMID[16640337] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 0.97 | nM | PMID[18307290] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 0.084 | nM | PMID[18307290] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | Ratio | = | 1.0 | n.a. | PMID[18307290] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 5.8 | nM | PMID[18083578] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 3.9 | nM | PMID[18083578] |
| NPT222 | Individual protein | Alpha-2a adrenergic receptor | Homo sapiens | Activity | = | 1.26 | n.a. | PMID[18077343] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 0.97 | nM | PMID[18752946] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 0.084 | nM | PMID[18752946] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 39.81 | nM | PMID[19317397] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 7.943 | nM | PMID[19317397] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 39.81 | nM | PMID[19317397] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 0.97 | nM | PMID[18553954] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 0.084 | nM | PMID[18553954] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 2.0 | nM | PMID[18553954] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 0.97 | nM | PMID[19366244] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 2.0 | nM | PMID[19366244] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 0.84 | nM | PMID[19366244] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 0.97 | nM | PMID[18651730] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 0.084 | nM | PMID[18651730] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 2.0 | nM | PMID[18651730] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 100.0 | nM | PMID[19362005] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 3.0 | nM | PMID[19362005] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 12.0 | nM | PMID[19362005] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 100.0 | nM | PMID[19232786] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 3.0 | nM | PMID[19232786] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 12.0 | nM | PMID[19232786] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | Kd | = | 50.0 | nM | PMID[19168263] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 100.0 | nM | PMID[19581100] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 1000.0 | nM | PMID[19581100] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 3.0 | nM | PMID[19581100] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 1000.0 | nM | PMID[19581100] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 12.0 | nM | PMID[19581100] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 1000.0 | nM | PMID[19581100] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 2.0 | nM | PMID[19608416] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 0.84 | nM | PMID[19608416] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 39.81 | nM | PMID[20462258] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 7.943 | nM | PMID[20462258] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 39.81 | nM | PMID[20462258] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 39.81 | nM | PMID[21652207] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 39.81 | nM | PMID[21696967] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 7.943 | nM | PMID[21696967] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 39.81 | nM | PMID[21696967] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 39.81 | nM | PMID[21925889] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 7.943 | nM | PMID[21925889] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 39.81 | nM | PMID[21925889] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | Kd | = | 251.19 | nM | PMID[23954364] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | Activity | = | 100.0 | % | PMID[24326276] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 0.2 | nM | PMID[24326276] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | Ki | = | 2.44 | nM | PMID[24326276] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | Ki | = | 192.0 | nM | PMID[24326276] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 86.0 | nM | PMID[26125514] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | Ki | = | 46.0 | nM | PMID[27132867] |
| NPT242 | Individual protein | Dopamine D1 receptor | Homo sapiens | Ki | > | 50000.0 | nM | PMID[27132867] |
| NPT243 | Individual protein | Dopamine D2 receptor | Homo sapiens | Ki | = | 48000.0 | nM | PMID[27132867] |
| NPT243 | Individual protein | Dopamine D2 receptor | Homo sapiens | Ki | = | 12000.0 | nM | PMID[27132867] |
| NPT244 | Individual protein | Dopamine D3 receptor | Homo sapiens | Ki | = | 4700.0 | nM | PMID[27132867] |
| NPT245 | Individual protein | Dopamine D4 receptor | Homo sapiens | Ki | = | 2900.0 | nM | PMID[27132867] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 87.0 | nM | PMID[27132867] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 120.0 | nM | PMID[27132867] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 3.2 | nM | PMID[28355078] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 13.0 | nM | PMID[28355078] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 86.0 | nM | PMID[28355078] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 0.7 | nM | PMID[29517238] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 0.3162 | nM | PMID[29751236] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 3.162 | nM | PMID[29751236] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | EC50 | = | 53.7 | nM | PMID[29751236] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 3.162 | nM | PMID[30392952] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 0.3162 | nM | PMID[30392952] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 1.2 | nM | PMID[31625751] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | Kd | = | 740.0 | nM | PMID[27239696] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | Kd | = | 130.0 | nM | PMID[27239696] |
| NPT109 | Individual protein | Cytochrome P450 3A4 | Homo sapiens | FC | = | 135.8 | n.a. | PMID[27397500] |
| NPT110 | Individual protein | Cytochrome P450 2D6 | Homo sapiens | FC | = | 100.1 | n.a. | PMID[27397500] |
| NPT212 | Individual protein | Cytochrome P450 2C9 | Homo sapiens | FC | = | 11.8 | n.a. | PMID[27397500] |
| NPT108 | Individual protein | Estrogen receptor alpha | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT303 | Individual protein | Vasopressin V1a receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT299 | Individual protein | Androgen Receptor | Rattus norvegicus | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT263 | Individual protein | Muscarinic acetylcholine receptor M2 | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT252 | Individual protein | Histamine H2 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT248 | Individual protein | Estrogen receptor beta | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT244 | Individual protein | Dopamine D3 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT228 | Individual protein | Norepinephrine transporter | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT267 | Individual protein | Neuropeptide Y receptor type 1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT245 | Individual protein | Dopamine D4 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT239 | Individual protein | Cholecystokinin A receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT291 | Individual protein | Serotonin 2b (5-HT2b) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 1000.0 | nM | PMID[35360904] |
| NPT1647 | Individual protein | Vasopressin V2 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT230 | Individual protein | Bradykinin B2 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT222 | Individual protein | Alpha-2a adrenergic receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT242 | Individual protein | Dopamine D1 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT295 | Individual protein | Serotonin transporter | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT217 | Individual protein | Adenosine A2a receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT1546 | Individual protein | Solute carrier family 22 member 3 | Homo sapiens | Activity | n.a. | n.a. | n.a. | PMID[36067397] |
| NPT232 | Individual protein | Cannabinoid CB1 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT2719 | Individual protein | Voltage-gated L-type calcium channel alpha-1C subunit | Rattus norvegicus | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT1788 | Individual protein | Alpha-1a adrenergic receptor | Homo sapiens | AC50 | = | 2116.6 | nM | PMID[37468498] |
| NPT1814 | Individual protein | Glucagon receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 147.91 | nM | PMID[38060818] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 1.259 | nM | PMID[34273662] |
| NPT1410 | Individual protein | GABA receptor alpha-1 subunit | Rattus norvegicus | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT251 | Individual protein | Histamine H1 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT1788 | Individual protein | Alpha-1a adrenergic receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT223 | Individual protein | Alpha-2b adrenergic receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT247 | Individual protein | Endothelin receptor ET-A | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT31 | Individual protein | Cyclooxygenase-2 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT2879 | Individual protein | Equilibrative nucleoside transporter 1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT224 | Individual protein | Alpha-2c adrenergic receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT249 | Individual protein | Glucocorticoid receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT2769 | Individual protein | Thromboxane A2 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | AC50 | = | 19.8 | nM | PMID[37468498] |
| NPT290 | Individual protein | Serotonin 2a (5-HT2a) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT261 | Individual protein | Monoamine oxidase A | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT264 | Individual protein | Muscarinic acetylcholine receptor M3 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | Intrinsic activity | = | 100.0 | % | PMID[34273662] |
| NPT1788 | Individual protein | Alpha-1a adrenergic receptor | Homo sapiens | AC50 | = | 9424.1 | nM | PMID[37468498] |
| NPT232 | Individual protein | Cannabinoid CB1 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT1163 | Individual protein | Glutamate (NMDA) receptor subunit zeta 1 | Rattus norvegicus | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT297 | Individual protein | Neurokinin 1 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 0.2138 | nM | PMID[34273662] |
| NPT262 | Individual protein | Muscarinic acetylcholine receptor M1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT218 | Individual protein | Adenosine A3 receptor | Homo sapiens | AC50 | = | 20290.8 | nM | PMID[37468498] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | AC50 | = | 928.4 | nM | PMID[37468498] |
| NPT246 | Individual protein | Dopamine transporter | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT292 | Individual protein | Serotonin 2c (5-HT2c) receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | AC50 | = | 593.5 | nM | PMID[37468498] |
| NPT1464 | Individual protein | Phosphodiesterase 4D | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | EC50 | = | 5.954 | nM | PMID[35360904] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | Emax | = | 100.0 | % | PMID[38060818] |
| NPT259 | Individual protein | Melanocortin receptor 4 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT216 | Individual protein | Adenosine A1 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT242 | Individual protein | Dopamine D1 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT243 | Individual protein | Dopamine D2 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT4558 | Individual protein | Beta-1 adrenergic receptor | Rattus norvegicus | IC50 | = | 5.3 | nM | PMID[1354264] |
| NPT4558 | Individual protein | Beta-1 adrenergic receptor | Rattus norvegicus | IC50 | = | 600.0 | nM | PMID[1354264] |
| NPT4558 | Individual protein | Beta-1 adrenergic receptor | Rattus norvegicus | Ki | = | 670.0 | nM | PMID[1672155] |
| NPT4913 | Individual protein | Beta-1 adrenergic receptor | Cavia porcellus | EC50 | = | 6.0 | nM | PMID[1672155] |
| NPT4558 | Individual protein | Beta-1 adrenergic receptor | Rattus norvegicus | EC20 | = | 0.15 | nM | PMID[12502364] |
| NPT968 | Protein family | Adrenergic receptor alpha-1 | Rattus norvegicus | Ki | = | 35500.0 | nM | PMID[8230093] |
| NPT4558 | Individual protein | Beta-1 adrenergic receptor | Rattus norvegicus | Ki | = | 80.0 | nM | PMID[8230093] |
| NPT968 | Protein family | Adrenergic receptor alpha-1 | Rattus norvegicus | Ki | = | 35500.0 | nM | PMID[1313109] |
| NPT4558 | Individual protein | Beta-1 adrenergic receptor | Rattus norvegicus | Ki | = | 80.0 | nM | PMID[1313109] |
| NPT4913 | Individual protein | Beta-1 adrenergic receptor | Cavia porcellus | ED50 | = | 2.2 | uM | PMID[619150] |
| NPT4913 | Individual protein | Beta-1 adrenergic receptor | Cavia porcellus | ED50 | = | 1.3 | uM | PMID[619150] |
| NPT4913 | Individual protein | Beta-1 adrenergic receptor | Cavia porcellus | ED50 | = | 2.1 | 10'-8M | PMID[20504] |
| NPT4913 | Individual protein | Beta-1 adrenergic receptor | Cavia porcellus | ED25 | = | 3.4 | nM | PMID[20504] |
| NPT713 | Individual protein | Bile salt export pump | Homo sapiens | IC50 | > | 1000000.0 | nM | PMID[21965623] |
| NPT713 | Individual protein | Bile salt export pump | Homo sapiens | IC50 | > | 986200.0 | nM | PMID[22961681] |
| NPT5318 | Individual protein | Corticotropin releasing factor receptor 1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT5301 | Individual protein | Motilin receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT30134 | Single protein | Gastric inhibitory polypeptide receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT29803 | Single protein | POU domain, class 2, transcription factor 1 | Homo sapiens | Activity | n.a. | n.a. | n.a. | PMID[36067397] |
| NPT987 | Individual protein | Histamine H3 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT4333 | Protein family | Adrenergic receptor beta | Rattus norvegicus | IC50 | = | 325.0 | nM | PMID[2887658] |
| NPT4333 | Protein family | Adrenergic receptor beta | Rattus norvegicus | EC50 | = | 7.0 | nM | PMID[1672155] |
| NPT972 | Protein family | Adrenergic receptor alpha | Rattus norvegicus | IC50 | > | 100000.0 | nM | PMID[6124637] |
| NPT4333 | Protein family | Adrenergic receptor beta | Rattus norvegicus | IC50 | = | 100.0 | nM | PMID[6124637] |
| NPT20556 | Single protein | Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 17.95 | % | DOI[10.6019/CHEMBL4495564] |
| NPT4358 | Individual protein | Type-1 angiotensin II receptor | Homo sapiens | AC50 | > | 100000.0 | nM | PMID[37468498] |
| NPT29430 | Single protein | Neuronal acetylcholine receptor protein alpha-4 subunit | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT4729 | Individual protein | Cholecystokinin B receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT3735 | Individual protein | Neurotensin receptor 1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT4358 | Individual protein | Type-1 angiotensin II receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT98 | Individual protein | HERG | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT542 | Individual protein | Progesterone receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT6179 | Individual protein | POU domain, class 2, transcription factor 2 | Homo sapiens | Activity | n.a. | n.a. | n.a. | PMID[36067397] |
| NPT3952 | Individual protein | Endothelin receptor ET-B | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT4915 | Individual protein | Beta-3 adrenergic receptor | Rattus norvegicus | EC50 | = | 13.0 | nM | PMID[1354264] |
| NPT970 | Protein family | Adrenergic receptor alpha-1 | Homo sapiens | EC50 | = | 1.5 | nM | PMID[1354264] |
| NPT4914 | Individual protein | Beta-2 adrenergic receptor | Cavia porcellus | EC50 | = | 58.0 | nM | PMID[1672155] |
| NPT4630 | Individual protein | Beta-2 adrenergic receptor | Bos taurus | Kd | = | 330.0 | nM | PMID[2993621] |
| NPT4630 | Individual protein | Beta-2 adrenergic receptor | Bos taurus | Ki | = | 110.0 | nM | PMID[8230093] |
| NPT4915 | Individual protein | Beta-3 adrenergic receptor | Rattus norvegicus | ED50 | = | 0.16 | mg.kg-1 | PMID[1350309] |
| NPT1386 | Protein family | Adrenergic receptor beta | Homo sapiens | EC50 | = | 30.0 | nM | PMID[6124637] |
| NPT4915 | Individual protein | Beta-3 adrenergic receptor | Rattus norvegicus | EC50 | = | 87.1 | nM | PMID[11311067] |
| NPT4630 | Individual protein | Beta-2 adrenergic receptor | Bos taurus | Ki | = | 110.0 | nM | PMID[1313109] |
| NPT4914 | Individual protein | Beta-2 adrenergic receptor | Cavia porcellus | EC50 | = | 31.62 | nM | PMID[22297114] |
| NPT4914 | Individual protein | Beta-2 adrenergic receptor | Cavia porcellus | EC50 | = | 28.84 | nM | PMID[23375225] |
| NPT4914 | Individual protein | Beta-2 adrenergic receptor | Cavia porcellus | EC50 | = | 31.62 | nM | PMID[24300734] |
| NPT4914 | Individual protein | Beta-2 adrenergic receptor | Cavia porcellus | EC50 | = | 31.64 | nM | PMID[24300734] |
| NPT4914 | Individual protein | Beta-2 adrenergic receptor | Cavia porcellus | ED50 | = | 7.8 | 10'-8M | PMID[619150] |
| NPT4914 | Individual protein | Beta-2 adrenergic receptor | Cavia porcellus | ED50 | = | 2.1 | 10'-8M | PMID[619150] |
| NPT4914 | Individual protein | Beta-2 adrenergic receptor | Cavia porcellus | ED50 | = | 7.1 | nM | PMID[20504] |
| NPT4914 | Individual protein | Beta-2 adrenergic receptor | Cavia porcellus | Kd | = | 17.78 | nM | PMID[25592716] |
| NPT4914 | Individual protein | Beta-2 adrenergic receptor | Cavia porcellus | Kd | = | 25.12 | nM | PMID[25592716] |
| NPT712 | Individual protein | Bile salt export pump | Rattus norvegicus | IC50 | > | 1000000.0 | nM | PMID[21965623] |
| NPT26430 | Single protein | Beta-1 adrenergic receptor | Mus musculus | Ki | = | 220.0 | nM | PMID[27132867] |
| NPT4914 | Individual protein | Beta-2 adrenergic receptor | Cavia porcellus | EC50 | = | 7.9 | nM | PMID[31625751] |
| NPT20859 | Single protein | Neuropeptide Y receptor type 2 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT92 | Individual protein | Serotonin 1a (5-HT1a) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT29454 | Single protein | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | Homo sapiens | Inhibition | = | -1.239 | % | PMID[38318365] |
| NPT5975 | Individual protein | Cyclooxygenase-1 | Rattus norvegicus | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT5104 | Individual protein | Phosphodiesterase 3A | Homo sapiens | AC50 | = | 17999.9 | nM | PMID[37468498] |
| NPT28448 | Single protein | Corticotropin releasing factor receptor 2 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT28814 | Single protein | Ghrelin receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT6127 | Individual protein | Bradykinin B1 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT28787 | Single protein | Voltage-gated N-type calcium channel alpha-1B subunit | Rattus norvegicus | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT4663 | Individual protein | Beta-2 adrenergic receptor | Canis lupus familiaris | IC50 | = | 1000.0 | nM | PMID[1354264] |
| NPT4663 | Individual protein | Beta-2 adrenergic receptor | Canis lupus familiaris | IC50 | = | 0.1 | nM | PMID[12502364] |
| NPT4632 | Individual protein | Beta-2 adrenergic receptor | Rattus norvegicus | IC50 | = | 0.1 | nM | PMID[12502364] |
| NPT969 | Protein family | Adrenergic receptor alpha-2 | Rattus norvegicus | Ki | = | 21000.0 | nM | PMID[8230093] |
| NPT4663 | Individual protein | Beta-2 adrenergic receptor | Canis lupus familiaris | IC50 | = | 0.1 | nM | PMID[11311067] |
| NPT969 | Protein family | Adrenergic receptor alpha-2 | Rattus norvegicus | Ki | = | 21000.0 | nM | PMID[1313109] |
| NPT543 | Individual protein | Pregnane X receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT425 | Individual protein | Serotonin 3a (5-HT3a) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT30151 | Single protein | Melanocortin receptor 3 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT306 | Cell line | PC-3 | Homo sapiens | FC | = | 0.955 | n.a. | PMID[16680159] |
| NPT4727 | Cell line | C3H 10T1/2 | Mus musculus | Activity | = | 291.3 | % | PMID[21330134] |
| NPT4727 | Cell line | C3H 10T1/2 | Mus musculus | EC50 | = | 19.0 | nM | PMID[21330134] |
| NPT520 | Cell line | 3T3-L1 | Mus musculus | Activity | = | 322.0 | % | PMID[28760530] |
| NPT18771 | Protein family | Beta-adrenergic receptor | Mus musculus | EC50 | = | 980.0 | nM | PMID[2859372] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | -0.07 | % | DOI[10.6019/CHEMBL4495565] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | DOI[10.6019/CHEMBL4651402] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | DOI[10.6019/CHEMBL4651402] |
| NPT28438 | Unchecked | Unchecked | n.a. | Ratio EC50 | > | 168.0 | n.a. | PMID[35360904] |
| NPT28438 | Unchecked | Unchecked | n.a. | pD2 | = | 7.84 | n.a. | PMID[34273662] |
| NPT28438 | Unchecked | Unchecked | n.a. | Selectivity ratio | = | 0.77 | n.a. | PMID[34273662] |
| NPT27601 | Tissue | Trachea | Cavia porcellus | Activity | = | 100.0 | % | PMID[35360904] |
| NPT28438 | Unchecked | Unchecked | n.a. | Emax | = | 180.57 | % | PMID[34273662] |
| NPT20529 | Non-molecular | NON-PROTEIN TARGET | n.a. | Inhibition | = | 49.0 | % | PMID[85712] |
| NPT938 | Organism | Cavia porcellus | Cavia porcellus | TIME | = | 0.05167 | hr | PMID[34273662] |
| NPT5998 | Organism | Mustela putorius furo | Mustela putorius furo | EC50 | = | 87.1 | nM | PMID[11311067] |
| NPT18776 | Selectivity group | Beta-2 adrenergic receptor and beta-3 adrenergic receptor | Homo sapiens | Ratio | = | 2.1 | n.a. | PMID[15603933] |
| NPT18776 | Selectivity group | Beta-2 adrenergic receptor and beta-3 adrenergic receptor | Homo sapiens | Ratio EC50 | = | 0.1 | n.a. | PMID[16640337] |
| NPT4557 | Others | Adrenergic receptor beta; ADRB1 & ADRB3 | Homo sapiens | Ratio EC50 | = | 0.3 | n.a. | PMID[16640337] |
| NPT4763 | Tissue | Heart | Mus musculus | Activity | = | 334.0 | bpm | PMID[23072318] |
| NPT4763 | Tissue | Heart | Mus musculus | Activity | = | -5882.0 | cmH2O/ms | PMID[23072318] |
| NPT4763 | Tissue | Heart | Mus musculus | Activity | = | 5330.0 | cmH2O/ms | PMID[23072318] |
| NPT4763 | Tissue | Heart | Mus musculus | Activity | = | 157.0 | cmH2O | PMID[23072318] |
| NPT2 | Others | Unspecified | n.a. | Kd | = | 0.00000098 | n.a. | PMID[2859372] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 0.99 | n.a. | PMID[12502364] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 0.1 | n.a. | PMID[11806709] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 0.3 | n.a. | PMID[11806709] |
| NPT2 | Others | Unspecified | n.a. | Ratio EC50 | = | 0.087 | n.a. | PMID[18307290] |
| NPT2 | Others | Unspecified | n.a. | EC50 | = | 199526231.5 | nM | PMID[19317397] |
| NPT2 | Others | Unspecified | n.a. | EC50 | = | 1000000000.0 | nM | PMID[19317397] |
| NPT2 | Others | Unspecified | n.a. | Ratio EC50 | = | 0.087 | n.a. | PMID[18553954] |
| NPT2 | Others | Unspecified | n.a. | Ratio EC50 | = | 2.1 | n.a. | PMID[18553954] |
| NPT2 | Others | Unspecified | n.a. | Ratio EC50 | = | 0.087 | n.a. | PMID[18752946] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 0.087 | n.a. | PMID[18651730] |
| NPT2 | Others | Unspecified | n.a. | Activity | = | 48.0 | % | PMID[16799554] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 370.0 | nM | PMID[16799554] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 150.0 | nM | PMID[16799554] |
| NPT2 | Others | Unspecified | n.a. | Ki | = | 90.0 | nM | PMID[16799554] |
| NPT2 | Others | Unspecified | n.a. | Ki | = | 50.0 | nM | PMID[16799554] |
| NPT2 | Others | Unspecified | n.a. | Activity | = | 214.39 | % | PMID[21330134] |
| NPT2 | Others | Unspecified | n.a. | Activity | = | 0.3 | mM | PMID[191614] |
| NPT2 | Others | Unspecified | n.a. | Activity | = | 3.12 | umol | PMID[191614] |
| NPT2 | Others | Unspecified | n.a. | ED50 | = | 7.1 | nM | PMID[19629] |
| NPT27 | Others | Unspecified | n.a. | ED25 | = | 3.4 | nM | PMID[19629] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 1.0 | n.a. | PMID[19629] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 0.48 | n.a. | PMID[19629] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 1.0 | n.a. | PMID[619150] |
| NPT2 | Others | Unspecified | n.a. | ED50 | = | 7.1 | 10'-9M | PMID[20503] |
| NPT2 | Others | Unspecified | n.a. | ED25 | = | 3.4 | 10'-9M | PMID[20503] |
| NPT2 | Others | Unspecified | n.a. | Ratio Ki | = | 260.0 | n.a. | PMID[27132867] |
| NPT2 | Others | Unspecified | n.a. | Ki | = | 78000.0 | nM | PMID[27132867] |
| NPT2 | Others | Unspecified | n.a. | Ki | = | 5700.0 | nM | PMID[27132867] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 0.99 | n.a. | PMID[29751236] |
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT938 | Organism | Cavia porcellus | Cavia porcellus | ED50 | = | 1.5 | M | PMID[3783603] |
| NPT938 | Organism | Cavia porcellus | Cavia porcellus | IC50 | = | 150.0 | nM | PMID[6150113] |
| NPT938 | Organism | Cavia porcellus | Cavia porcellus | EC50 | = | 6.2 | nM | PMID[7277389] |
| NPT938 | Organism | Cavia porcellus | Cavia porcellus | EC50 | = | 3.2 | nM | PMID[7277389] |
| NPT938 | Organism | Cavia porcellus | Cavia porcellus | ED50 | = | 1.5 | M | PMID[3783604] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | ED50 | = | 0.001 | mg.kg-1 | PMID[6453996] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | ED25 | = | 1.0 | ug kg-1 | PMID[6453996] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Potency | = | 0.11 | nM kg-1 | PMID[7277389] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Potency | = | 0.35 | nM kg-1 | PMID[7277389] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | ED50 | = | 0.0014 | umol.kg-1 | PMID[6115058] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | ED50 | = | 0.0008 | umol.kg-1 | PMID[6115058] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | ED25 | = | 0.019 | ug/kg | PMID[894683] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | ED50 | = | 0.000069 | mg.kg-1 | PMID[894683] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Inhibition | > | 70.0 | % | PMID[950653] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Inhibition | = | 20.0 | % | PMID[950653] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | > | 60.0 | % | PMID[950653] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 40.0 | % | PMID[950653] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 20.0 | % | PMID[950653] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EC50 | = | 226.0 | nM | PMID[2887658] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EC50 | = | 10.0 | nM | PMID[11311067] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 0.0006 | mg.kg-1 | PMID[11311067] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 13.64 | pmol/Kg | PMID[35360904] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 27.93 | pmol/g | PMID[35360904] |
Experimental ADME
| Experiment Model | Experiment Tissue | ADME Type | ADME Relation | ADME Value | ADME Unit | Reference |
|---|
Experimental Toxicity
| Experiment Model | Experiment Organism | Toxicity Type | Toxicity Relation | Toxicity Value | Toxicity Unit | Reference |
|---|
Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria
| Hepatotoxicity | Carcinogenicity | Mutagenicity | Cardiotoxicity | Respiratory Toxicity | Eye Irritation | Endocrine Disruption |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]
  Chemically structural similarityTop-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)
Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.
●  The left chart: Distribution of similarity level between NPC483291 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC483291 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).
| Similarity Score | Similarity Level | Drug ID | Developmental Stage |
|---|---|---|---|
| 1.0 | High Similarity | NPD601 | Phase 4 |
| 0.9688 | High Similarity | NPD597 | Approved |
| 0.8378 | Intermediate Similarity | NPD598 | Approved |
| 0.7353 | Intermediate Similarity | NPD9620 | Phase 2 |
| 0.7353 | Intermediate Similarity | NPD9621 | Phase 4 |
| 0.6667 | Remote Similarity | NPD9384 | Phase 4 |
| 0.6216 | Remote Similarity | NPD602 | Phase 4 |
| 0.6098 | Remote Similarity | NPD5314 | Phase 2 |
| 0.6 | Remote Similarity | NPD9622 | Phase 4 |
| 0.575 | Remote Similarity | NPD1136 | Phase 4 |
| 0.5682 | Remote Similarity | NPD9619 | Approved |
| 0.561 | Remote Similarity | NPD1132 | Approved |
| 0.537 | Remote Similarity | NPD2978 | Phase 4 |
| 0.5349 | Remote Similarity | NPD599 | Approved |
| 0.5273 | Remote Similarity | NPD2977 | Approved |
| 0.5227 | Remote Similarity | NPD823 | Approved |
| 0.5122 | Remote Similarity | NPD316 | Phase 4 |
| 0.5116 | Remote Similarity | NPD9381 | Approved |
| 0.5111 | Remote Similarity | NPD817 | Approved |
  Bioactivity similaritySimilarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.
